Drug pricing and transparency in Europe and the United States: what is it and how does it work?
Authors:
- 1 February 2024
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Pharmacoeconomics & Outcomes Research
- Vol. 24 (4) , 477-486
Abstract
Introduction: As drug prices are viewed to be opaque, there have been increasing societal demands on policy and decision makers to implement initiatives that promote drug price transparency. Areas covered: This Perspective discusses what drug price transparency is and how it works in theory and in practice. Expert opinion: Transparency on drug prices may target payers, patients and health care professionals; and may relate to prices at each stage in a drug's distribution system. Although proponents claim that drug price transparency will reduce prices and increase patient access, others expect the opposite effect. Nevertheless, a number of international organizations, countries and consumer groups have taken steps to enhance drug price transparency. This has occurred despite a lack of theoretical clarity and of evidence about its likely impact. Policy and decision makers need to consider how payers and pharmaceutical companies are likely to react to drug price transparency and need to be aware that transparency may produce different effects depending on the country to which it is applied. Even though we believe that full drug price transparency is elusive, various incremental measures can be taken to move toward it.Keywords
This publication has 52 references indexed in Scilit:
- Multi-Indication Pricing: Pros, Cons, And Its Applicability To The United KingdomValue in Health, 2016
- Innovation in the pharmaceutical industry: New estimates of R&D costsJournal of Health Economics, 2016
- Promoting Cost Transparency to Reduce Financial Harm to PatientsAMA Journal of Ethics, 2015
- Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policiesCochrane Database of Systematic Reviews, 2014
- Enhancing medicine price transparency through price information mechanismsGlobalization and Health, 2014
- Clarifying Costs: Can Increased Price Transparency Reduce Healthcare Spending?SSRN Electronic Journal, 2013
- Pharmaceutical Companies’ Variation Of Drug Prices Within And Among Countries Can Improve Long-Term Social Well-BeingHealth Affairs, 2011
- A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countriesGlobalization and Health, 2011
- Would Greater Transparency And Uniformity Of Health Care Prices Benefit Poor Patients?Health Affairs, 2007
- Price Differentiation and Transparency in the Global Pharmaceutical MarketplacePharmacoEconomics, 2005